When normalized to the CK-SOX10 tumor biomarker, an elevated tumor NOS2 expression gradient (12) defined by weak, medium, or strong (NOS2s) expression levels was observed that correlated with poor outcome (Figure 1B). The gene discussed is SOX10; the disease is neoplasm.